vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and OLD SECOND BANCORP INC (OSBC). Click either name above to swap in a different company.

Core Laboratories Inc. is the larger business by last-quarter revenue ($121.8M vs $93.8M, roughly 1.3× OLD SECOND BANCORP INC). OLD SECOND BANCORP INC runs the higher net margin — 27.3% vs 4.2%, a 23.1% gap on every dollar of revenue. Over the past eight quarters, OLD SECOND BANCORP INC's revenue compounded faster (15.1% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

U.S. Bancorp is an American multinational banking institution headquartered in Minneapolis, Minnesota and incorporated in Delaware. It is the 5th-largest bank in the United States as of 2025. As the largest bank in the Midwestern United States, it is considered systemically important by the Financial Stability Board. It is the parent company of its primary operating entity, U.S. Bank National Association, which does business as U.S. Bank. The company provides banking, investment, mortgage, tr...

CLB vs OSBC — Head-to-Head

Bigger by revenue
CLB
CLB
1.3× larger
CLB
$121.8M
$93.8M
OSBC
Higher net margin
OSBC
OSBC
23.1% more per $
OSBC
27.3%
4.2%
CLB
Faster 2-yr revenue CAGR
OSBC
OSBC
Annualised
OSBC
15.1%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CLB
CLB
OSBC
OSBC
Revenue
$121.8M
$93.8M
Net Profit
$5.1M
$25.6M
Gross Margin
Operating Margin
1.5%
Net Margin
4.2%
27.3%
Revenue YoY
-1.4%
Net Profit YoY
159.2%
EPS (diluted)
$0.11
$0.48

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
OSBC
OSBC
Q1 26
$121.8M
$93.8M
Q4 25
$138.3M
$95.2M
Q3 25
$134.5M
$95.9M
Q2 25
$130.2M
$75.1M
Q1 25
$123.6M
$73.1M
Q4 24
$129.2M
$73.2M
Q3 24
$134.4M
$71.2M
Q2 24
$130.6M
$70.8M
Net Profit
CLB
CLB
OSBC
OSBC
Q1 26
$5.1M
$25.6M
Q4 25
$4.9M
Q3 25
$14.2M
$9.9M
Q2 25
$10.6M
$21.8M
Q1 25
$-154.0K
$19.8M
Q4 24
$7.4M
Q3 24
$11.7M
$23.0M
Q2 24
$9.0M
$21.9M
Gross Margin
CLB
CLB
OSBC
OSBC
Q1 26
Q4 25
20.8%
Q3 25
22.0%
Q2 25
20.3%
Q1 25
19.5%
Q4 24
17.8%
Q3 24
20.5%
Q2 24
21.2%
Operating Margin
CLB
CLB
OSBC
OSBC
Q1 26
1.5%
Q4 25
11.5%
41.2%
Q3 25
15.6%
13.6%
Q2 25
11.7%
38.9%
Q1 25
3.6%
35.8%
Q4 24
11.0%
34.7%
Q3 24
14.7%
41.9%
Q2 24
12.3%
41.2%
Net Margin
CLB
CLB
OSBC
OSBC
Q1 26
4.2%
27.3%
Q4 25
3.6%
Q3 25
10.6%
10.3%
Q2 25
8.2%
29.0%
Q1 25
-0.1%
27.1%
Q4 24
5.7%
Q3 24
8.7%
32.3%
Q2 24
6.9%
30.9%
EPS (diluted)
CLB
CLB
OSBC
OSBC
Q1 26
$0.11
$0.48
Q4 25
$0.11
$0.53
Q3 25
$0.30
$0.18
Q2 25
$0.22
$0.48
Q1 25
$0.00
$0.43
Q4 24
$0.15
$0.42
Q3 24
$0.25
$0.50
Q2 24
$0.19
$0.48

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
OSBC
OSBC
Cash + ST InvestmentsLiquidity on hand
$22.8M
$115.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$275.1M
$893.3M
Total Assets
$587.7M
$6.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
OSBC
OSBC
Q1 26
$22.8M
$115.7M
Q4 25
$22.7M
$124.0M
Q3 25
$25.6M
$116.5M
Q2 25
$31.2M
$141.8M
Q1 25
$22.1M
$256.1M
Q4 24
$19.2M
$99.3M
Q3 24
$21.5M
$115.8M
Q2 24
$17.7M
$120.9M
Total Debt
CLB
CLB
OSBC
OSBC
Q1 26
Q4 25
$110.3M
Q3 25
$114.1M
Q2 25
$124.6M
Q1 25
$124.4M
Q4 24
$126.1M
Q3 24
$139.9M
Q2 24
$147.6M
Stockholders' Equity
CLB
CLB
OSBC
OSBC
Q1 26
$275.1M
$893.3M
Q4 25
$266.0M
$896.8M
Q3 25
$271.3M
$866.7M
Q2 25
$261.3M
$718.6M
Q1 25
$253.4M
$694.5M
Q4 24
$246.6M
$671.0M
Q3 24
$250.7M
$661.4M
Q2 24
$240.3M
$619.3M
Total Assets
CLB
CLB
OSBC
OSBC
Q1 26
$587.7M
$6.8B
Q4 25
$584.0M
$6.9B
Q3 25
$591.4M
$7.0B
Q2 25
$602.1M
$5.7B
Q1 25
$591.5M
$5.7B
Q4 24
$585.1M
$5.6B
Q3 24
$600.5M
$5.7B
Q2 24
$597.8M
$5.7B
Debt / Equity
CLB
CLB
OSBC
OSBC
Q1 26
Q4 25
0.41×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
OSBC
OSBC
Operating Cash FlowLast quarter
$4.0M
Free Cash FlowOCF − Capex
$517.0K
FCF MarginFCF / Revenue
0.4%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.77×
TTM Free Cash FlowTrailing 4 quarters
$22.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
OSBC
OSBC
Q1 26
$4.0M
Q4 25
$7.9M
$122.3M
Q3 25
$8.5M
$35.9M
Q2 25
$13.9M
$24.2M
Q1 25
$6.7M
$17.8M
Q4 24
$20.6M
$131.5M
Q3 24
$13.1M
$48.5M
Q2 24
$17.1M
$11.6M
Free Cash Flow
CLB
CLB
OSBC
OSBC
Q1 26
$517.0K
Q4 25
$5.0M
$117.8M
Q3 25
$6.5M
$34.7M
Q2 25
$10.4M
$23.5M
Q1 25
$3.9M
$16.2M
Q4 24
$17.4M
$120.7M
Q3 24
$10.4M
$46.2M
Q2 24
$14.3M
$8.7M
FCF Margin
CLB
CLB
OSBC
OSBC
Q1 26
0.4%
Q4 25
3.6%
123.7%
Q3 25
4.8%
36.2%
Q2 25
8.0%
31.2%
Q1 25
3.1%
22.2%
Q4 24
13.4%
165.0%
Q3 24
7.7%
64.9%
Q2 24
10.9%
12.3%
Capex Intensity
CLB
CLB
OSBC
OSBC
Q1 26
Q4 25
2.1%
4.7%
Q3 25
1.5%
1.3%
Q2 25
2.7%
1.1%
Q1 25
2.3%
2.2%
Q4 24
2.5%
14.7%
Q3 24
2.0%
3.3%
Q2 24
2.2%
4.2%
Cash Conversion
CLB
CLB
OSBC
OSBC
Q1 26
0.77×
Q4 25
1.61×
Q3 25
0.60×
3.64×
Q2 25
1.31×
1.11×
Q1 25
0.90×
Q4 24
2.78×
Q3 24
1.12×
2.11×
Q2 24
1.90×
0.53×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLB
CLB

Segment breakdown not available.

OSBC
OSBC

Net Interest Income$81.1M87%
Noninterest Income$12.6M13%

Related Comparisons